Table 1.

Cell Surface Phenotype of Different EBV-Infected Transformed T-Cell Lines

CD2CD3TCRCD4CD8CD28CD25CD45RACD45ROCD56HLA-DRCD44
EBV 41 97 78 73 68 100 85 10 
EBV 32 93 94 69 97 100 87 
T1B5 99 92 94 87 100 89 
TFS 90 97 89 87 100 92 14 
E1V 85 81 97 47 100 87 10 
2C8 99 95 79 94 100 93 
2G4 95 97 91 94 100 12 96 
2G8 96 94 42 67 100 99 
NC5 98 99 96 98 100 97 10 
TC 100 98 95 94 100 89 
CD2CD3TCRCD4CD8CD28CD25CD45RACD45ROCD56HLA-DRCD44
EBV 41 97 78 73 68 100 85 10 
EBV 32 93 94 69 97 100 87 
T1B5 99 92 94 87 100 89 
TFS 90 97 89 87 100 92 14 
E1V 85 81 97 47 100 87 10 
2C8 99 95 79 94 100 93 
2G4 95 97 91 94 100 12 96 
2G8 96 94 42 67 100 99 
NC5 98 99 96 98 100 97 10 
TC 100 98 95 94 100 89 

Results are expressed as the percentage of positive cells. Cells were stained with saturating amounts of FITC- or PE-conjugated MoAbs (Becton Dickinson) and analyzed by using a cytofluometer (Epics; Becton Dickinson). EBV 41 and EBV 32 were isolated from donor 1; T1B5, TFS, and E1V from donor 2; 2C8, 2G4, and 2G8 and NC5 from donor 3. TC cells were isolated from a solid tumor in a RAG2-deficient after subcutaneous injection of NC5 cells.

Close Modal

or Create an Account

Close Modal
Close Modal